These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2227081)

  • 21. A comparison of the effects of two modified release preparations of nifedipine-nifedipine retard 10 mg twice daily and nifedipine GITS 20 mg once daily--in the treatment of mild to moderate hypertension.
    Kirby BJ; Kitchin NR
    Int J Clin Pract; 1999; 53(5):339-43. PubMed ID: 10695096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lisinopril versus slow-release nifedipine in the treatment of mild to moderate hypertension: a multicentre study. The Cooperative Study Group.
    Witchitz S; Serradimigni A
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():29-33. PubMed ID: 2550643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Essential arterial hypertension: therapeutic experience with "nifedipine A. R."].
    Sandullo A; Colletti A; Violante C; Russo M; Toto C; Di Leo R
    Riv Eur Sci Med Farmacol; 1987 Dec; 9(4):459-63. PubMed ID: 3508621
    [No Abstract]   [Full Text] [Related]  

  • 24. Early side-effects of antihypertensive therapy: comparison of amlodipine and nifedipine retard.
    Bremner AD; Fell PJ; Hosie J; James IG; Saul PA; Taylor SH
    J Hum Hypertens; 1993 Feb; 7(1):79-81. PubMed ID: 8450526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Current aspects of drug correction of impaired circulation in the ocular vessels].
    Kiseleva TN; Polunin GS; Lagutina IuM
    Vestn Oftalmol; 2007; 123(2):37-9. PubMed ID: 17650609
    [No Abstract]   [Full Text] [Related]  

  • 26. The relationship between digital and ocular vasospasm.
    Guthauser U; Flammer J; Mahler F
    Graefes Arch Clin Exp Ophthalmol; 1988; 226(3):224-6. PubMed ID: 3402743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Preliminary evaluation of the use of nifedipine in peripheral circulatory disorders on a functional basis].
    Cornacchia D; Finzi CM; Marchi G
    Boll Soc Ital Cardiol; 1978; 23(9):1523-5. PubMed ID: 553626
    [No Abstract]   [Full Text] [Related]  

  • 28. [A clinical case: coronary vasospasm induced by exercise after stopping nifedipine therapy].
    Oneglia C; Sabatini T; Ghizzoni G; Rusconi C
    Minerva Cardioangiol; 1992 Mar; 40(3):109-14. PubMed ID: 1630675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of vasospasm on visual function.
    Gasser P; Flammer J
    Doc Ophthalmol; 1987 May; 66(1):3-18. PubMed ID: 3322745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conversion from sustained-release to immediate-release calcium entry blockers: outcome in patients with mild-to-moderate hypertension.
    Hilleman DE; Mohiuddin SM; Lucas BD; Shinn B; Elsasser GN
    Clin Ther; 1993; 15(6):1002-10. PubMed ID: 8111798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nipple vasospasms, Raynaud's syndrome, and nifedipine.
    Garrison CP
    J Hum Lact; 2002 Nov; 18(4):382-5. PubMed ID: 12449056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-substitution of nifedipine slow-release preparations.
    Van Veenhuyzen D; Coetzee R
    S Afr Med J; 2002 Nov; 92(11):838, 840. PubMed ID: 12506575
    [No Abstract]   [Full Text] [Related]  

  • 33. Short- and long-term efficacy of nifedipine in hypertensive patients with impaired renal function, with special reference to influencing factors.
    Matsukawa S; Suzuki H; Itaya Y; Nakajima S; Saruta T
    J Clin Hypertens; 1987 Dec; 3(4):452-62. PubMed ID: 3134514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparison of chlorthalidone and sustained-action nifedipine in the treatment of mild to moderate arterial hypertension].
    Martínez de la Iglesia J; de Diego Cabrera MS; González Santos C; Iribarren Marín MA; Calderón de la Barca Gázquez JM; Pérula Torres L
    Aten Primaria; 1990 Apr; 7(4):258, 260, 262-4. PubMed ID: 2102750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of long-term nifedipine treatment on body fluid composition in essential hypertension.
    Toftdahl DB; Andersen GS
    J Hum Hypertens; 1989 Jun; 3(3):203-6. PubMed ID: 2769676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nifedipine reduces pulmonary pressure and vascular tone during short- but not long-term treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease.
    Agostoni P; Doria E; Galli C; Tamborini G; Guazzi MD
    Am Rev Respir Dis; 1989 Jan; 139(1):120-5. PubMed ID: 2912331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antihypertensive efficacy of a slow release nifedipine tablet formulation given once daily in patients with mild to moderate hypertension. A placebo-controlled, double-blind parallel-group trial.
    Harder S; Rietbrock S; Thürmann P
    Arzneimittelforschung; 1994 Feb; 44(2):133-6. PubMed ID: 8147945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Tolerance to delayed-action nifedipine].
    Robles NR; Lobos JM; Seguido P; Lahoz F
    Med Clin (Barc); 1989 Mar; 92(11):438. PubMed ID: 2725101
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficacy and tolerance of nifedipine retard vs acebutolol in patients with essential hypertension treated for 26 weeks.
    Chamiec T; Zaleska T; Kłoś J; Pietrzykowska H; Bednarz B; Ceremuzyński L
    Mater Med Pol; 1989; 21(1):49-52. PubMed ID: 2634218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective controlled trial of two nifedipine extended release formulations in the treatment of essential hypertension.
    Pivac N; Naranca M; Vujic-Podlipec D; Bagatin J; Rumboldt Z
    Arzneimittelforschung; 2002; 52(5):379-84. PubMed ID: 12087923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.